logo
Select company
Select metric
$ 55.69MNet Cash Flow - Financing
VS
Market
21
Sector
20
Industry
26
History
7
$ 80.13Close
$ 4.63 - $ 102.05 52-Week Range
Ticker Information

Ticker

MNPR

Company Name

MONOPAR THERAPEUTICS

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MONOPAR THERAPEUTICS - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MNPR - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 55.69M
3/31/2025$ 55.99M
12/31/2024$ 59.29M
9/30/2024$ 3.49M
6/30/2024$ 3.75M
3/31/2024$ 4.4M
12/31/2023$ 2.03M
9/30/2023$ 1.83M
6/30/2023$ 1.56M
3/31/2023$ 854.34K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MONOPAR THERAPEUTICS's latest trailing twelve months (TTM) CF - Financing stands at $ 17.58M.
  • Over the past 5 years, MONOPAR THERAPEUTICS's average CF - Financing has been $ 13.62M.
  • The median CF - Financing for MONOPAR THERAPEUTICS during this period was $ 4.08M
  • MONOPAR THERAPEUTICS reached its highest CF - Financing over the past 5 years at $ 59.29M.
  • The lowest CF - Financing recorded by MONOPAR THERAPEUTICS in the same timeframe $ -113.64K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

MNPR - Net Cash Flow - Financing, Last 5 years

$ -113.64K

Minimum

Sep 30, 2022

$ 59.29M

Maximum

Dec 31, 2024

$ 13.62M

Average

$ 4.08M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M